$KD

Kyndryl stock fell 9.4% after missing Q4 earnings expectations, though analysts argue solid free cash flow guidance suggests the selloff may be overreaction.

Rosen Law Firm urges Kyndryl investors with $100K+ losses to meet April 13, 2026 lead plaintiff deadline in securities class action alleging financial misstatements and control deficiencies.

Hagens Berman files expanded class action against $KD alleging undisclosed cash management practices masked financial health. Stock down 55% following SEC investigation and executive departures.

Hagens Berman files securities class action against Kyndryl for allegedly manipulating free cash flow metrics. Stock plummeted 55% after SEC investigation disclosure and executive departures.

Law firm sues Kyndryl ($KD) for alleged securities fraud involving misstated financials and undisclosed problems. Stock crashed 54.9% after executive departures and SEC inquiry.

Kyndryl Holdings faces 55% stock collapse after SEC financial reporting investigation and executive departures. Class action lawsuit filed; deadline April 13, 2026.

Law offices announce securities fraud class actions against $PSFE, $INO, and $KD with lead plaintiff deadlines April 7-13, 2026.

Kyndryl faces class action lawsuit alleging securities fraud, false statements, and control failures. Investors who purchased stock August 2024-February 2026 may be eligible.

Rosen Law Firm files securities lawsuit against Ultragenyx Pharmaceutical over alleged misleading claims about setrusumab's effectiveness; April 6 deadline for investors with $100K+ losses.

Rosen Law Firm urges $KD investors to join securities class action alleging false financial statements and internal control failures. April 13 deadline to serve as lead plaintiff.

Hagens Berman sued Kyndryl for allegedly manipulating free cash flow metrics. Stock crashed 55% after SEC investigation disclosure and executive departures.

Kyndryl faces securities fraud class action after CFO departure, SEC investigation into cash management, and delayed quarterly filing. Stock crashed 54.9%.

Kirby McInerney LLP filed securities fraud lawsuit against ImmunityBio over allegedly misleading Anktivas marketing. FDA warning letter triggered 21.2% stock decline.

Oil surges 84% while Bitcoin crashes 23% in Q1 2026, signaling major rotation from speculative growth toward energy and tangible assets.

Law firm Kahn Swick & Foti files class action against $ENPH alleging financial misstatements; April 20, 2026 deadline for lead plaintiff applications.

Law firm launches class action against $KYD over alleged securities fraud, citing missed filings, control weaknesses, and executive departures following stock plunge.

Pomerantz Law Firm files securities fraud suit against PayPal after disappointing Q4 earnings, CEO exit, and 2027 guidance withdrawal. Investors have until April 20, 2026, for Lead Plaintiff status.

Kyndryl Holdings stock crashes 55% following SEC investigation disclosure and three executive departures. Class action filed; investor deadline April 13, 2026.

Rosen Law Firm encourages Power Solutions International investors to join securities class action before lead plaintiff deadlines. Allegations include overstated sales capabilities and understated manufacturing costs.

Rosen Law Firm is recruiting investors in $KD, Alight, and Inovio for securities class actions alleging false statements and inadequate disclosure.